23-gauge Pars Plana Vitrectomy With Silicone Oil Injectionsilicone Oil Injection With Surgical

Sponsor
Ain Shams University (Other)
Overall Status
Completed
CT.gov ID
NCT04280770
Collaborator
(none)
50
2
49.9

Study Details

Study Description

Brief Summary

Objective: to evaluate anatomical and visual outcomes of 23-gauge vitrectomy for retinal detachment with silicone oil injection in fifty cases. The rate of recurrence, the incidence of proliferative vitreoretinopathy (PVR) and the value of risk factors.

Participants and Methods: fifty cases with RD with mixture of epiretinal and subretinal membranes were collected. Pars plan vitrectomy, 23gauge vitrectomy were done to these cases, then silicone oil removed 6 weeks after primary surgery.

Main Outcome Measures: The anatomical success rate,the failure rate ,the rate of retinal breaks in both groups, and reproliferation rate.

Condition or Disease Intervention/Treatment Phase
  • Procedure: 23 PARS PLANA VITRECTOMY
N/A

Detailed Description

50 Patients were included if they had retinal detachment, moderate degrees of PVR, PVR ≥ Grade C, previous buckle surgery and pseudophakia. A good and correct assessment of the detached retina was done. Investigator followed the Lincoff rules to find the retinal breaks. Investigator performed a three-port vitrectomy: one infusion trocar and two instruments trocars. Non-contact wide-angle viewing systems (Resight- Biom) have a viewing field of 60-130° was used. Investigator used Perfluorocarbon liquid (PFCL) for attaching the retina with its gravity. Then performing PFCL against air exchange.The retina will be attached under air tamponade. Laser photocoagulation was performed in the air-filled eye.

Investigator applied the laser effects confluently surrounding all retinal breaks. Then silicone oil (1000 centistokes) was injected as a final step and permanent tamponade.After 3-6 months investigator removed the silicone and examined the retina for 6 weeks after surgery to detect the recurrent cases.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Fifty participants were assigned and divided into two groups. Participants without RD after SO removal was recruited into group A-NRD, and participants with RD after SO removal was recruited into group B-RD.Fifty participants were assigned and divided into two groups. Participants without RD after SO removal was recruited into group A-NRD, and participants with RD after SO removal was recruited into group B-RD.
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description:
Each of the recruited patients were assigned a study number and randomized in accordance with a simple block randomization scheme.
Primary Purpose:
Treatment
Official Title:
Surgical Techniques for Epiretinal Membrane Removal in Pars Plana Vitrectomy: A Comparative Study Between 20-Gauge and 23-Gauge Vitrectomy
Actual Study Start Date :
Jan 30, 2009
Actual Primary Completion Date :
Mar 11, 2013
Actual Study Completion Date :
Mar 30, 2013

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Non retinal detachment group

35 participants did 23 vitrectomy followed for 3-6 months. After that, we removed the oil and followed them for 6 weeks.

Procedure: 23 PARS PLANA VITRECTOMY
We performed a three-port vitrectomy: one infusion trocar and two instruments trocars. Non-contact wide-angle viewing systems (Resight- Biom) have a viewing field of 60-130° was used. Put 23 needle attached to the automated pump for silicone oil extraction. Strict examination of the retina to detect new breaks or untreated breaks. Closure of the sclerotomies.
Other Names:
  • SILICONE OIL REMOVAL
  • Active Comparator: retinal detachment group

    15 participants did 23 vitrectomy followed for 3-6 months. After that, we removed the oil and followed them for 6 weeks.

    Procedure: 23 PARS PLANA VITRECTOMY
    We performed a three-port vitrectomy: one infusion trocar and two instruments trocars. Non-contact wide-angle viewing systems (Resight- Biom) have a viewing field of 60-130° was used. Put 23 needle attached to the automated pump for silicone oil extraction. Strict examination of the retina to detect new breaks or untreated breaks. Closure of the sclerotomies.
    Other Names:
  • SILICONE OIL REMOVAL
  • Outcome Measures

    Primary Outcome Measures

    1. success rate [42 days]

      success rate after first RD surgery and silicone oil removal

    2. The failure rate [42 days]

      The failure rate after silicone oil removal

    3. number of surgical interference [4 years]

      numbers of vitrectomies done after silicone oil removal

    Secondary Outcome Measures

    1. lower retinal breaks [4 years]

      The rate of lower retinal breaks in RD group versus the rate of lower retinal breaks in NRD group was

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    23 Years to 58 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • they had retinal detachment,

    • moderate degrees of PVR

    • PVR ≥ Grade C

    • previous buckle surgery

    • pseudophakia.

    Exclusion Criteria:
    • the retinal tear was greater than 90 degrees

    • presence of intravitreal foreign body

    • previous vitrectomy done before

    • if follow-up data were unavailable for a minimum follow-up of 6 months following the final retinal procedure.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Ain Shams University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    khaled hamdi elbaklish, Clinical Professor, Ain Shams University
    ClinicalTrials.gov Identifier:
    NCT04280770
    Other Study ID Numbers:
    • FWA000017585 FMASU 25/2017
    First Posted:
    Feb 21, 2020
    Last Update Posted:
    Feb 24, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by khaled hamdi elbaklish, Clinical Professor, Ain Shams University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 24, 2020